Trials / Conditions / Non-Resectable Pancreas Carcinoma
Non-Resectable Pancreas Carcinoma
4 registered clinical trials studyying Non-Resectable Pancreas Carcinoma — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Firstline Sequential AG and mFOLFOX Combined With Serplulimab and Bevacizumab Versus AG Chemotherapy Alone in NCT07235930 | Zhejiang Cancer Hospital | Phase 3 |
| Suspended | Evaluation of the High Intensity Focused Ultrasound (HIFU) Technique for Patients With Unresectable Pancreatic NCT06211933 | Centre Leon Berard | Phase 1 / Phase 2 |
| Recruiting | Gemcitabine Versus Reduced-dose Combination Chemotherapy in Fragile Patients with Non-resectable Pancreatic Ca NCT05841420 | Morten Ladekarl | Phase 2 |
| Recruiting | Sequential AG and mFOLFOX Combined With Serplulimab Injection and Bevacizumab Injection in Untreated Advanced NCT06393166 | Zhejiang Cancer Hospital | Phase 2 |